Tenet Healthcare Corp (THC) with a beta value of 1.78 appears to be a promising investment opportunity.

On Tuesday, Tenet Healthcare Corp (NYSE: THC) opened lower -0.82% from the last session, before settling in for the closing price of $134.50. Price fluctuations for THC have ranged from $90.03 to $171.20 over the past 52 weeks.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Sponsored

During the last 5-year period, the sales growth of Healthcare Sector giant was 2.41%. Company’s average yearly earnings per share was noted 2.54% at the time writing. With a float of $93.02 million, this company’s outstanding shares have now reached $95.11 million.

Let’s determine the extent of company efficiency that accounts for 98000 employees. In terms of profitability, gross margin is 35.63%, operating margin of 16.15%, and the pretax margin is 25.4%.

Tenet Healthcare Corp (THC) Breakdown of a Key Holders of the stock

A key investor’s attitude towards the stock of the Medical Care Facilities industry is another important factor to consider. The insider ownership of Tenet Healthcare Corp is 2.21%, while institutional ownership is 95.51%. The most recent insider transaction that took place on Mar 11 ’25, was worth 1,194,752. In this transaction Director of this company sold 9,525 shares at a rate of $125.43, taking the stock ownership to the 27,378 shares. Before that another transaction happened on Mar 11 ’25, when Company’s Director proposed sale 9,525 for $125.80, making the entire transaction worth $1,198,245.

Tenet Healthcare Corp (THC) Recent Fiscal highlights

According to the Wall Street analysts, stocks earnings will be around 2.54% per share during the next fiscal year.

Tenet Healthcare Corp (NYSE: THC) Trading Performance Indicators

Check out the current performance indicators for Tenet Healthcare Corp (THC). In the past quarter, the stock posted a quick ratio of 1.70. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.61. Likewise, its price to free cash flow for the trailing twelve months is 11.37.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 32.23, a number that is poised to hit 3.16 in the next quarter and is forecasted to reach 13.23 in one year’s time.

Technical Analysis of Tenet Healthcare Corp (THC)

Looking closely at Tenet Healthcare Corp (NYSE: THC), its last 5-days average volume was 1.29 million, which is a drop from its year-to-date volume of 1.49 million. As of the previous 9 days, the stock’s Stochastic %D was 74.72%. Additionally, its Average True Range was 5.08.

During the past 100 days, Tenet Healthcare Corp’s (THC) raw stochastic average was set at 30.37%, which indicates a significant decrease from 78.36% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 34.83% in the past 14 days, which was lower than the 36.94% volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $132.47, while its 200-day Moving Average is $143.65. However, in the short run, Tenet Healthcare Corp’s stock first resistance to watch stands at $135.29. Second resistance stands at $137.18. The third major resistance level sits at $138.40. If the price goes on to break the first support level at $132.18, it is likely to go to the next support level at $130.96. Now, if the price goes above the second support level, the third support stands at $129.07.

Tenet Healthcare Corp (NYSE: THC) Key Stats

There are currently 95,121K shares outstanding in the company with a market cap of 12.69 billion. Presently, the company’s annual sales total 20,665 M according to its annual income of 3,200 M. Last quarter, the company’s sales amounted to 5,072 M and its income totaled 318,000 K.